1 – 5 of 20
- show: 5
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
The engineered CD80 variant fusion therapeutic davoceticept combines checkpoint antagonism with conditional CD28 costimulation for anti-tumor immunity
(
- Contribution to journal › Article
-
Mark
Suppression of T-Cell Proliferation by Normal Density Granulocytes Led to CD183 Downregulation and Cytokine Inhibition in T-Cells
(
- Contribution to journal › Article
-
Mark
Two subsets of human marginal zone B cells resolved by global analysis of lymphoid tissues and blood
(
- Contribution to journal › Article
- 2017
-
Mark
Host-Derived CD70 Suppresses Murine Graft-versus-Host Disease by Limiting Donor T Cell Expansion and Effector Function
(
- Contribution to journal › Article
- 2013
-
Mark
Granzyme B-mediated damage of CD8+ T cells impairs graft-versus-tumor effect
(
- Contribution to journal › Article